Same Indication

Lisinopril vs Nivolumab

Lisinopril vs Nivolumab: Overview

This comparison examines the pharmacological differences between Lisinopril and Nivolumab.

Mechanism of Action

Lisinopril: ACE inhibitor preventing conversion of angiotensin I to angiotensin II.

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Pharmacokinetics

Half-life: Lisinopril — 12 hours; Nivolumab — 27 days.

Chemical Properties

Molecular Formula: Lisinopril — C21H31N3O5.

Molecular Weight: Lisinopril — 405.4900 g/mol.

Type: Lisinopril — Small molecule; Nivolumab — Antibody.